Introduction
Centromeres are essential for the process of stable chromosome inheritance. They are the site of kinetochore formation and are responsible for attachment to, and movement along microtubules for the faithful separation of chromosomes during mitotic and meiotic cell divisions. In recent years, there have been major efforts in the study of simple and complex centromeres and in the application of centromere knowledge for the construction of human engineered chromosomes (HECs) to provide a tool to further understand chromosome and centromere properties, and for potential gene delivery and expression studies in gene therapy. Other authors in this volume have covered the use of conventional centromeres that contain repetitive DNA in HEC construction. We will focus specifically on the use of non-repetitive DNA-based centromeres (or neocentromeres) to achieve HEC construction, and discuss some of the unique applications of the ensuing HECs.
Neocentromere discovery and its wide distribution within the human genome
In 1993, we described the first neocentromere lacking the ␣-satellite DNA traditionally associated with human centromere function. 1 This neocentromere was identified on a mitotically stable marker chromosome, designated mardel (10) , that was devoid of normal centromeric ␣-satellite DNA but had acquired a fully functional kinetochore at an interstitial 10q25 region with a DNA content that appears unaltered from the progenitor chromosome 10.
2-6 Recently, we have used a procedure based on chromatin immunoprecipitation and array (CIA) analysis to determine the distribution pattern of the histone-H3-related centromere binding protein CENP-A -a key component of the centromeric nucleosome that distinguishes functional centromeres from the surrounding chromatin. Using this procedure, which involves immunoprecipitation of centromeric chromatin and the hybridization of the extracted DNA to contiguous genomic BAC arrays constructed across neocentromeric regions, we have identified a 330 kb and 460 kb CENP-A-binding domain on the 10q25 and a second 20p12 neocentromere, respectively. 7, 8 Up to the present time, over 51 cases of human neocentromeres originating from 18 different human chromosomes have been described at different genomic locations, thus establishing neocentromeres as a relatively widespread phenomenon within the human genome.
9,10

Construction of neocentromere-based minichromosomes (NC-MiCs)
We have employed the strategy of telomere-associated chromosome truncation to remove non-essential chromosome arms to produce minichromosomes in situ. Human telomeric DNA consists of simple tandem repeats of a hexanucleotide TTAGGG sequence. By introducing small arrays of cloned telomeric DNA into cells, it is possible to truncate the distal portion of a chromosomal arm hence leading to the seeding of a new telomere at the site of integration. Targeted truncation is facilitated by the inclusion of homologous genomic sequences within the truncation construct. Through sequential rounds of targeted truncation using homologous sequences in close proximity to the neocentromere, both chromosomal arms can be removed resulting in minichromosome formation. Other authors in this volume and elsewhere, 11, 12 have described the use of this procedure for the sequential truncation of a human X and Y chromosome to yield a number of ␣-satellite-containing minichromosomes.
Using this procedure, we have successfully produced a series of NC-MiCs by truncation of the mardel(10) chromosome at the long-and short-arm regions near the neocentromere in the human HT1080 cell line (Figures 1a  and 2) . 13 Despite the use of homologous sequences to encourage site-specific truncation, detailed analysis of the resulting NC-MiCs indicated a mixed outcome of specific targeting and apparently non-targeted, random trunc- Gene Therapy ation events. In addition to the NC-MiCs shown in Figure  1 , our more recent studies have generated NC-MiCs in which both the mardel(10) chromosomal arms were truncated through specific targeting events to yield minichromosomes whose constructions are fully predictable in accordance with the experimental design (data not shown). Structural analyses of the NC-MiCs have included FISH using whole-chromosome paint for each of the 24 human chromosomes, sub-regional paints for chromosome 10, and individual BACs from a 5-Mb contiguous array spanning the 10q25 neocentromeric/perineocentromeric region, as well as selected PCR and/or sequencing studies. The results indicated that irrespective of whether truncations had occurred specifically or randomly, the NC-MiCs were shown to contain single-copy DNA derived from the predicted 10q25 genomic region, with no detectable rearrangements or untoward alterations to the neocentromeric and perineocentromeric domains. These NC-MiCs ranged in size from approximately 650 kb to 2 Mb.
The structural morphology of the NC-MiCs was studied by FISH using a pan-telomere probe, immunofluorescence using an antibody to the telomere repeat-binding factor TRF1, and pulsed field gel electrophoresis (which resolves only linear and not circular DNA). The results indicated that some of the NC-MiCs were linear, while others were apparently circular in structure (Figure 1) .
The original NC-MiCs showed mitotic stability of between 35-80% in long-term culture for over 60 cell divisions with or without drug selection pressure. Subcloning of these NC-MiC-containing cell lines consistently yielded cell lines demonstrating >85% NC-MiC retention after >100 cell divisions in the absence of selection, suggesting that the decreased instability observed in the original cell lines was likely to be related to the inherent genomic instability of the particular HT1080 cell line used in this study, for which we have additional evidence to support. 13 The presence of a fully functional neocentromere on the NC-MiCs was further confirmed by the binding of a host of key centromere-associated proteins including CENP-A, CENP-C, CENP-E, CENP-F, hZW10, p55CDC, and Bub1 (see Figure 2 for an example).
Applications of neocentromere-based minichromosomes
The NC-MiCs described represent the first examples of mitotically and structurally stable engineered mammalian minichromosomes lacking centromeric repeats. The absence of large tracts of simple repeats, and the availability of fully known genomic DNA sequences of the neocentromere-based minichromosomes provide advantages in at least three different areas of studies compared with the use of repetitive DNA-based mammalian artificial chromosomes.
The first application is in the dissection of the functional domains of complex mammalian centromeres using human neocentromeres as a model system. In earlier studies, we have demonstrated that the availability of well-defined genomic reference markers, in combination with the CIA analysis method mentioned above, have allowed the high-resolution mapping of the CENP-Abinding domains of two different human neocentromeres. 7, 8 These studies have provided the first direct evi-dence for the extent of CENP-A binding on any higher eukaryotic centromere. The same strategy can be readily applied to other centromere-binding proteins allowing an accurate mapping of the relative distribution profile for each of these proteins. In addition, it can be used for determining other centromeric and pericentromeric properties, such as the pattern of DNA replication timing, 7 scaffold attachment, cohesion, and histone acetylation. Although such mapping studies can be performed on the original neocentromere-containing marker chromosomes as we have shown, 7, 8 chromosome truncation experiments provide an important means to allow the direct ascertainment of the functional role of the different domains. In this respect, we have demonstrated, using our smallest 650-kb NC-MiC5, that the minimal 330-kb CENP-A-binding domain of the mardel(10) neocentromere and approximately 320 kb of additional DNA flanking this domain are sufficient to provide full kinetochore activity, 7 (see Figure 1) . The 650-kb NC-MiC5 has also allowed us to infer that a neocentromere-related 1-Mb region of significantly delayed replication flanking one side of the CENP-A-binding domain can be deleted without affecting neocentromere function, suggesting that the formation of such a domain of delayed replication timing is not obligatory to centromere function. 7 Future work aimed at further terminal or interstitial truncation of the minichromosomes, including portions of the CENP-A-binding domain, should allow us to study in detail the functional roles and importance of individual centromeric and pericentromeric domains.
The second application extends those described above to the whole chromosome. Thus, in addition to the dissection of functions specific to the centromere, the NC-MiCs provide excellent models of fully operational mammalian chromosomes in which both their small sizes and fully known nucleotide sequence contents should make them unique and tractable experimental tools for defining the properties of the higher eukaryotic chromosomes. Some of these properties overlap those described above for the centromere, but extend across the entire minichromosome, including the telomeric ends. In addition, such minichromosomes may facilitate the investigation of agents that damage chromosome function, cellular mechanisms that repair such damages, and other processes that affect chromosome dynamics.
A third potential application of the NC-MiCs is to serve as an improved tool for the delivery of genes in gene therapy. Numerous authors have recently discussed the pros and cons of using mammalian artificial chromosomes for this application in general, [14] [15] [16] [17] and have also specifically compared and contrasted the use of repetitive DNA-based versus neocentromere-based HECs. [15] [16] [17] Because of their predictable mode of construction, fully definable sequence nature, and the potential to be smaller than the repetitive DNA-based HECs, the NC-MiCs bear a number of theoretical advantages over other types of HECs for gene therapy applications. Whether these theoretical advantages are realisable will depend on the outcome of further detailed investigation of the NC-MiCs. Such investigations should include further attempts at downsizing existing NC-MiCs, determining the fidelity of the regulation and expression of inserted genes, stability in different cell lines in culture and in whole animal, and establishing efficient methods for their isolation and transfer into cells.
